Work for IBIO, Inc.?

Claim Your Profile

IBIO, Inc. Logo Image

IBIO, Inc.

IBIO, Inc. has reached its limit for report views.

Please check back to see if IBIO, Inc. has upgraded their profile page to allow their financial information to be viewed. In the meantime, here are a few annual reports from similar companies.

Most Recent Annual Report

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

2016 Annual Report, Interactive Annual Report and Form 10K

IBIO, Inc.

Upgrade your company profile to unlock all of your annual report content on AnnualReports.com

Archived Annual Reports

About IBIO, Inc.

11-50 Employees
Based in New York, New York

iBio is developing proprietary products for the treatment of a range of fibrotic diseases including idiopathic pulmonary fibrosis, systemic sclerosis, and scleroderma. IBIO-CFB03, produced using the Company's proprietary gene expression technology, is the first product candidate from this program being advanced for IND development. The Company also offers proprietary products and product licenses to others based on its proprietary technologies, providing collaborators full support for turn-key implementation of its technology for protein therapeutics and vaccines.

Ticker:
IBIO
Exchange:
NYSE (See More NYSE Companies)
Industry:
Biotechnology (See More Biotechnology Companies)
Sector:
Healthcare (See More Healthcare Companies)

Looking for Other Annual Reports?

Search by company name or ticker symbol